Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine

Sannette Hall, Devendra K. Agrawal

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Cardiovascular diseases including atherosclerosis are a major financial and health burden globally. Inflammation associated with atherosclerosis results in the development of plaques that can rupture causing thrombosis, stroke, or death. The most widely used treatment for the removal of atherosclerotic plaques is percutaneous transluminal coronary angioplasty (PTCA) with or without stenting. Although this is a safer and minimally invasive method, restenosis and intimal hyperplasia after interventional procedure remains a major hurdle and more refined approaches are needed. Studies in large animal models such as pigs have facilitated a greater understanding of the underlying mechanisms of the disease and provided novel targets for therapeutic intervention. In pre-clinical studies, viral vector gene therapy has emerged as a promising option for the reduction and/or prevention of restenosis and intimal hyperplasia. Although studies in animal models have generated promising results, clinical trials have yet to prove the clinical efficacy of gene therapy in coronary artery diseases. In this review, we examined and critically reviewed the most recent advances in viral vector gene therapy obtained from studies using porcine model of atherosclerosis.

Original languageEnglish (US)
Pages (from-to)918-927
Number of pages10
JournalDrug Delivery and Translational Research
Issue number4
StatePublished - Aug 1 2018

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science


Dive into the research topics of 'Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine'. Together they form a unique fingerprint.

Cite this